Vertex Pharmaceuticals Inc
XMUN:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XMUN:VX1
|
US |
|
T
|
thyssenkrupp AG
XMUN:TKA
|
DE |
|
Mare Engineering Group SpA
F:EZ3
|
IT |
|
D
|
Dubber Corp Ltd
F:O5A
|
AU |
|
W
|
Welsbach Technology Metals Acquisition Corp
OTC:WTMA
|
US |
Shareholder Yield
Current shareholder yield for 
VX1 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
VX1 Price
Vertex Pharmaceuticals Inc
| Average Annual Return | 23.21% |
| Standard Deviation of Annual Returns | 17.29% |
| Max Drawdown | -34% |
| Market Capitalization | 108B EUR |
| Shares Outstanding | 119 583 344 |
| Percentage of Shares Shorted |
N/A
|
